U.K. Medicines And Healthcare Products Regulatory Agency Authorizes Eli Lilly's Onswik For Adults With Type 2 Diabetes

The U.K. Medicines and Healthcare Products Regulatory Agency has authorized Eli Lilly's Onswik (efsitora alfa) for use in adults with Type 2 diabetes. This approval marks a significant step for Eli Lilly in expanding its diabetes treatment portfolio. The stock ticker for Eli Lilly is LLY.